MACC1-induced Migration in Tumors: Current State and Perspective
Overview
Affiliations
Malignant tumors are still a global, heavy health burden. Many tumor types cannot be treated curatively, underlining the need for new treatment targets. In recent years, metastasis associated in colon cancer 1 (MACC1) was identified as a promising biomarker and drug target, as it is promoting tumor migration, initiation, proliferation, and others in a multitude of solid cancers. Here, we will summarize the current knowledge about MACC1-induced tumor cell migration with a special focus on the cytoskeletal and adhesive systems. In addition, a brief overview of several models used for the analysis of cell migration is given. In this context, we will point to issues with the currently most prevalent models used to study MACC1-dependent migration. Lastly, open questions about MACC1-dependent effects on tumor cell migration will be addressed.
Zhu Y, Lv X, Li R, Gao Z, Lei C, Wang L Adv Pharmacol Pharm Sci. 2024; 2024:2653426.
PMID: 39544485 PMC: 11561180. DOI: 10.1155/2024/2653426.
Choi B, Lee D, Park J, Hong T, Kim O, Lee S Int J Mol Sci. 2024; 25(17).
PMID: 39273182 PMC: 11394864. DOI: 10.3390/ijms25179232.
Torke S, Walther W, Stein U Cancers (Basel). 2024; 16(7).
PMID: 38611008 PMC: 11010928. DOI: 10.3390/cancers16071330.
Balijepalli P, Yue G, Prasad B, Meier K Int J Mol Sci. 2024; 25(4).
PMID: 38396744 PMC: 10889543. DOI: 10.3390/ijms25042067.
Chang L, Hung S, Chou Y, Chen C, Li J, Lin C J Cancer. 2023; 14(18):3532-3538.
PMID: 38021160 PMC: 10647202. DOI: 10.7150/jca.90130.